New imaging method could improve cancer staging accuracy
NCT ID NCT04840472
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 13 times
Summary
This early-phase study tests a new imaging agent called 111In-panitumumab to see if it can safely and accurately find cancer that has spread to lymph nodes in people with head and neck cancer. About 28 participants will receive an injection of this agent before surgery, and its ability to spot cancerous lymph nodes will be compared to the standard method using dye during surgery. The goal is to improve staging and guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.